166 related articles for article (PubMed ID: 26287798)
1. Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis.
Wang Z; Katsaros D; Shen Y; Fu Y; Canuto EM; Benedetto C; Lu L; Chu WM; Risch HA; Yu H
PLoS One; 2015; 10(8):e0136246. PubMed ID: 26287798
[TBL] [Abstract][Full Text] [Related]
2. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
3. Bub1 is required for maintaining cancer stem cells in breast cancer cell lines.
Han JY; Han YK; Park GY; Kim SD; Lee CG
Sci Rep; 2015 Nov; 5():15993. PubMed ID: 26522589
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer.
Ocaña A; Pérez-Peña J; Díez-González L; Sánchez-Corrales V; Templeton A; Seruga B; Amir E; Pandiella A
Breast Cancer Res Treat; 2016 Feb; 156(1):1-8. PubMed ID: 26897635
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the major mitotic checkpoint genes and risk of breast cancer: a multigenic study on cancer susceptibility.
Wang P; Wang Y; Yan H; Xie Q; Zhao L; Xu S; Zhao Q
Tumour Biol; 2014 Jul; 35(7):6701-5. PubMed ID: 24711138
[TBL] [Abstract][Full Text] [Related]
6. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer.
Li L; Xu DB; Zhao XL; Hao TY
Arch Gynecol Obstet; 2013 Jul; 288(1):155-65. PubMed ID: 23334889
[TBL] [Abstract][Full Text] [Related]
7. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
8. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
13. [Expression of NUF2 in breast cancer and its clinical significance].
Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
[TBL] [Abstract][Full Text] [Related]
17. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma.
Ortiz-Martínez F; Sanmartín E; Pomares-Navarro E; Pérez-Balaguer A; Andrés L; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
Am J Clin Pathol; 2015 Jun; 143(6):812-22. PubMed ID: 25972323
[TBL] [Abstract][Full Text] [Related]
19. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells.
Percy MJ; Myrie KA; Neeley CK; Azim JN; Ethier SP; Petty EM
Genes Chromosomes Cancer; 2000 Dec; 29(4):356-62. PubMed ID: 11066082
[TBL] [Abstract][Full Text] [Related]
20. RECK is not an independent prognostic marker for breast cancer.
Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]